Mechanisms linking cerebrovascular dysfunction and tauopathy: adding a layer of epiregulatory complexity

Yoon A. Kim,Marian Mellen,Caghan Kizil,Ismael Santa‐Maria
DOI: https://doi.org/10.1111/bph.16280
IF: 7.3
2023-11-07
British Journal of Pharmacology
Abstract:Intracellular accumulation of hyperphosphorylated misfolded tau proteins is found in many neurodegenerative tauopathies, including Alzheimer's disease (AD). Tau pathology can impact cerebrovascular physiology and function through multiple mechanisms. In vitro and in vivo studies have shown that alterations in the blood brain barrier integrity and function can result in synaptic abnormalities and neuronal damage. In the present article, we will summarize how tau proteostasis dysregulation contributes to vascular dysfunction and conversely, we will examine the factors and pathways leading to tau pathological alterations triggered by cerebrovascular dysfunction. Finally, we will highlight the role epigenetic and epitranscriptomic factors play in regulating the integrity of the cerebrovascular system and the progression of tauopathy including a few remarks on potential therapeutic interventions.
pharmacology & pharmacy
What problem does this paper attempt to address?